Crinetics Pharmaceuticals, Inc. (CRNX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CRNX. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR LLC | 15,759,799 | $572M | INCREASED |
| BlackRock, Inc. | 8,478,815 | $308M | INCREASED |
| FARALLON CAPITAL MANAGEMENT LLC | 8,338,098 | $303M | INCREASED |
| WELLINGTON MANAGEMENT GROUP LLP | 8,157,204 | $296M | INCREASED |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 6,395,922 | $232M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Stephanie Okey (Director) | AWARD | 9,730 | $349K | 2026-06-18 |
| Stephanie Okey (Director) | AWARD | 5,925 | 2026-06-18 | |
| Wendell Wierenga (Director) | AWARD | 9,730 | $349K | 2026-06-18 |
| Wendell Wierenga (Director) | AWARD | 5,925 | 2026-06-18 | |
| Camille L Bedrosian (Director) | AWARD | 9,730 | $349K | 2026-06-18 |
Full institutional holdings, insider history, and congressional trades for Crinetics Pharmaceuticals, Inc. on SentiSense.